Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × crofelemer × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Cancer Therapy-Related Diarrhea 1

Interventions

Carboplatin 9 Cisplatin 7 Pemetrexed 6 Nivolumab 5 Vincristine 4 Topotecan 3 Ipilimumab 3 Injections 3 Etoposide 3 Doxorubicin 3 Talc 2 Specimen Handling 2 Radiotherapy 2 Paclitaxel 2 Granulocyte Colony-Stimulating Factor 2 Gemcitabine 2 Filgrastim 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 ranpirnase 1 raltitrexed 1 pertuzumab 1 pembrolizumab 1 iniparib 1 durvalumab 1 dostarlimab 1 crofelemer 1 atezolizumab 1 Vorinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04538625 2024-07-26

OnTARGET

Napo Pharmaceuticals, Inc.

Phase 3 Completed

Other solid neoplasm

Cancer Therapy-Related Diarrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡